The Future Role of Anti-Tumour Necrosis Factor- Products in the Treatment of Crohn's Disease

Author： van Hogezand R.A.   Verspaget H.W.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.56, Iss.3, 1998-09, pp. : 299-305

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Future Role of Anti-Tumour Necrosis Factor (TNF) Products in the Treatment of Rheumatoid Arthritis

By Camussi G.   Lupia E.  

Drugs, Vol. 55, Iss. 5, 1998-05 ,pp. : 613-620

Adis International

Access to resources Recommend Favorite

Anti-tumour necrosis factor therapy in seronegative spondyloarthritis

By Swales Catherine   Bowness Paul  

Clinical Medicine, Vol. 5, Iss. 3, 2005-05 ,pp. : 219-222

Royal College Of Physicians

Access to resources Recommend Favorite

Tumour necrosis factor (TNF) inhibitors are an effective option in the management of Crohn's disease

By  

Drugs & Therapy Perspectives, Vol. 26, Iss. 9, 2010-09 ,pp. : 15-18

Adis International

Access to resources Recommend Favorite

Optimizing the Use of Tumour Necrosis Factor Inhibitors in Crohn's Disease: A Practical Approach

By >   Ordás Ingrid   Ricart Elena  

Drugs, Vol. 70, Iss. 2, 2010-01 ,pp. : 109-120

Adis International

Access to resources Recommend Favorite

Structure-Modifying Capacity of Anti-Tumour Necrosis Factor- Therapy in Ankylosing Spondylitis

By Filip De Keyser   Baeten Dominique   Filip Van den Bosch   Kruithof Elli   Verbruggen Gust   Mielants Herman   Veys Eric  

Drugs, Vol. 64, Iss. 24, 2004-01 ,pp. : 2793-2811

Adis International

Access to resources Recommend Favorite